3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia
2
Hematologic Neoplasms
2
Myocarditis
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, T-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Febrile Neutropenia
1
Disease
1
Interventions
Meropenem
3
Ceftazidime
3
Filgrastim
2
Ciprofloxacin
2
Cefepime
2
ceftolozane, tazobactam drug combination
1
Vancomycin
1
Teicoplanin
1
Simvastatin
1
Positron Emission Tomography Computed Tomography
1
Ofloxacin
1
NF protocol
1
Micafungin
1
Metronidazole
1
Levofloxacin
1
Itraconazole
1
Granulocyte Colony-Stimulating Factor
1
Cilastatin, Imipenem Drug Combination
1
Anti-Bacterial Agents
1
Amikacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Febrile Neutropenia
×
Positron Emission Tomography Computed Tomography
×
Other hematologic neoplasm
×
Clear all
NCT03429387
2022-05-17
PIPPIN
Peter MacCallum Cancer Centre, Australia
Phase NA
Completed
147 enrolled